The Regulatory Accountability Act of 2017 - Implications for FDA Regulation and Public Health

N Engl J Med. 2018 Feb 1;378(5):412-414. doi: 10.1056/NEJMp1711643. Epub 2017 Dec 20.

Authors

Jonathan J Darrow¹, Erin C Fuse Brown¹, Aaron S Kesselheim¹

Affiliation

¹ From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (J.J.D., A.S.K.); and the Georgia State University College of Law, Atlanta (E.C.F.B.).

PMID: 29261363
DOI: 10.1056/NEJMp1711643

No abstract available

MeSH terms

Economics
Government Regulation*
Public Health / legislation & jurisprudence*
United States
United States Food and Drug Administration / legislation & jurisprudence*